Ogechi Ikediobi

Ogechi Ikediobi

UNVERIFIED PROFILE

Are you Ogechi Ikediobi?   Register this Author

Register author
Ogechi Ikediobi

Ogechi Ikediobi

Publications by authors named "Ogechi Ikediobi"

Are you Ogechi Ikediobi?   Register this Author

12Publications

215Reads

37Profile Views

Familial secondary hyperhidrosis associated with tumor necrosis factor-alpha inhibitor treatment.

JAAD Case Rep 2015 Nov 26;1(6):418-20. Epub 2015 Nov 26.

Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2015.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809394PMC
November 2015

Pharmacogenetics in dermatology: a patient-centered update.

Int J Dermatol 2013 Aug 20;52(8):1005-12. Epub 2013 Jun 20.

Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-4632.2012.05793.xDOI Listing
August 2013

Pharmacogenomic applications in oncology.

J Pharm Pract 2012 Aug;25(4):439-46

UNC School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, Chapel Hill, NC 27599-7569, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190012448308DOI Listing
August 2012

Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes?

Per Med 2011 Nov;8(6):669-679

Department of Community Health Sciences, SUNY Downstate School of Public Health, 450 Clarkson Avenue, Box #43, Brooklyn, NY 11203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme.11.67DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242007PMC
November 2011

Analysis of pharmacogenetic traits in two distinct South African populations.

Hum Genomics 2011 May;5(4):265-82

University of California, San Francisco, School of Pharmacy, Department of Clinical Pharmacy, CA 94143, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525241PMC
May 2011

The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.

Hum Genomics 2010 Apr;4(4):238-49

Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525209PMC
April 2010

Multifactorial regulation of E-cadherin expression: an integrative study.

Mol Cancer Ther 2010 Jan 6;9(1):1-16. Epub 2010 Jan 6.

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-0321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821037PMC
January 2010

In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.

Mol Cancer Ther 2008 Jun 4;7(6):1337-46. Epub 2008 Jun 4.

Genomics and Bioinformatics Group, Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-2308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705835PMC
June 2008

Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug.

J Aerosol Med 2002 ;15(3):261-70

Division of Pharmaceutics, College of Pharmacy, Florida A&M University, Tallahassee, Florida 32307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/089426802760292609DOI Listing
November 2002